Drug Shortage Report for TEVA-NABILONE

Last updated on 2018-09-13 History
Report ID 2256
Drug Identification Number 02384884
Brand name TEVA-NABILONE
Common or Proper name NABILONE
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) NABILONE
Strength(s) 0.5MG
Dosage form(s) CAPSULE
Route of administration ORAL
Packaging size 50
ATC code A04AD
ATC description ANTIEMETICS AND ANTINAUSEANTS
Reason for shortage Demand increase for the drug.
Anticipated start date 2018-02-15
Actual start date 2018-02-15
Estimated end date 2018-07-15
Actual end date 2018-08-30
Shortage status Resolved
Updated date 2018-09-13
Company comments
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v19 2018-09-13 French Compare
v18 2018-09-13 English Compare
v17 2018-07-03 French Compare
v16 2018-07-03 English Compare
v15 2018-03-07 French Compare
v14 2018-03-07 English Compare
v13 2018-02-16 English Compare
v12 2017-11-23 French Compare
v11 2017-11-23 English Compare
v10 2017-10-10 French Compare
v9 2017-10-10 English Compare
v8 2017-09-16 English Compare
v7 2017-07-27 French Compare
v6 2017-07-27 English Compare
v5 2017-04-29 English Compare
v4 2017-04-03 French Compare
v3 2017-04-03 English Compare
v2 2017-03-14 French Compare
v1 2017-03-14 English Compare